Section Arrow
GBIO.NASDAQ
- Generation Bio Co
(Financial Status)
Quotes are at least 15-min delayed:2025/04/15 14:49 EDT
Last
 0.3801
+0.0061 (+1.63%)
Day High 
0.3979 
Prev. Close
0.374 
1-M High
0.5913 
Volume 
249.44K 
Bid
0.3801
Ask
0.3813
Day Low
0.37 
Open
0.3728 
1-M Low
0.316 
Market Cap 
25.06M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.37 
20-SMA 0.43 
50-SMA 0.54 
52-W High 4.34 
52-W Low 0.316 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.98/-1.06
Enterprise Value
105.61M
Balance Sheet
Book Value Per Share
1.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.89M
Operating Revenue Per Share
0.01
Created with Highstock 5.0.121-min Chart10:3012:3014:300.360.370.380.390.4etnet.com.hk@copyright
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MURAMural Oncology plc2.4492+1.4192+137.79%-- 
SKYESkye Bioscience1.67+0.36+27.48%3.58PE
SPRBSpruce Biosciences0.1346-0.1798-57.19%-- 
VERVVerve Therapeutics5.051+0.931+22.60%-- 
DWTXDogwood Therapeutics Inc4.01+1.01+33.67%-- 
Quotes are at least 15-min delayed:2025/04/15 14:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform isits novel iqDNA, which is an optimized variant of its ceDNA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.